APOE and Alzheimer disease: Overall, the distinction that APOE4 represents a loss of positive function in neuroinflammation rather than a gain of negative function is important with respect to development of AD treatment strategies, suggesting that APOE4 carriers would benefit from strategies designed to correct the structure/function of apoE4 rather than eliminate apoE4.